State Of New Jersey Common Pension Fund D Allogene Therapeutics, Inc. Transaction History

State Of New Jersey Common Pension Fund D

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$21.01 - $27.64 $1.75 Million - $2.3 Million	-83,099 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$23.49 - $35.8 $259,869 - $396,055	11,063 Added 15.36%	83,099 $2.17 Million
Q1 2021 Apr 27, 2021	BUY	$25.79 - $39.02 $339,963 - $514,361	13,182 Added 22.4%	72,036 $2.54 Million
Q4 2020 Feb 03, 2021	SELL	$25.24 - $43.45 $155,226 - $267,217	-6,150 Reduced 9.46%	58,854 $1.49 Million
Q3 2020 Oct 27, 2020	BUY	$32.38 - $44.96 $697,465 - $968,438	21,540 Added 49.56%	65,004 $2.45 Million
Q2 2020 Aug 04, 2020	BUY	$18.39 - $54.04 $799,302 - $2.35 Million	43,464 New	43,464 $1.86 Million

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.